{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T11:30:17Z","timestamp":1781782217256,"version":"3.54.5"},"reference-count":387,"publisher":"Oxford University Press (OUP)","issue":"suppl_F","license":[{"start":{"date-parts":[[2018,5,31]],"date-time":"2018-05-31T00:00:00Z","timestamp":1527724800000},"content-version":"vor","delay-in-days":30,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,5,1]]},"DOI":"10.1093\/eurheartj\/suy019","type":"journal-article","created":{"date-parts":[[2018,5,31]],"date-time":"2018-05-31T07:08:50Z","timestamp":1527750530000},"page":"F1-F74","source":"Crossref","is-referenced-by-count":31,"title":["Consensus Document ANMCO\/ANCE\/ARCA\/GICR-IACPR\/GISE\/SICOA: Long-term Antiplatelet Therapy in Patients with Coronary Artery Disease"],"prefix":"10.1093","volume":"20","author":[{"given":"Michele Massimo","family":"Gulizia","sequence":"first","affiliation":[{"name":"U.O.C. di Cardiologia, Ospedale Garibaldi-Nesima, Azienda di Rilievo Nazionale e Alta Specializzazione \u201cGaribaldi\u201d, Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Furio","family":"Colivicchi","sequence":"additional","affiliation":[{"name":"U.O.C. Cardiologia e UTIC, Ospedale San Filippo Neri, Roma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio Giuseppe","family":"Abrignani","sequence":"additional","affiliation":[{"name":"U.O.C. di Cardiologia e UTIC, Ospedale Civile Sant'Antonio Abate, Erice, Trapani, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Ambrosetti","sequence":"additional","affiliation":[{"name":"Servizio di Cardiologia Riabilitativa, Clinica Le Terrazze Cunardo, Varese, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Aspromonte","sequence":"additional","affiliation":[{"name":"U.O. Scompenso e Riabilitazione Cardiologica, Polo Scienze Cardiovascolari, Toraciche, Policlinico Agostino Gemelli, Roma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Barile","sequence":"additional","affiliation":[{"name":"Poliambulatorio ASL RM C\/D11, Roma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Caporale","sequence":"additional","affiliation":[{"name":"U.O.C. Cardiologia Interventistica, Ospedale Annunziata, Cosenza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Casolo","sequence":"additional","affiliation":[{"name":"S.C. Cardiologia, Nuovo Ospedale Versilia, Lido di Camaiore (LU), Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Chiuini","sequence":"additional","affiliation":[{"name":"Specialista Ambulatoriale Cardiologo, ASL Umbria 1, Perugia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Di Lenarda","sequence":"additional","affiliation":[{"name":"S.C. Cardiovascolare e Medicina dello Sport, Azienda Sanitaria Universitaria Integrata di Trieste, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pompilio","family":"Faggiano","sequence":"additional","affiliation":[{"name":"U.O. Cardiologia Spedali Civili, Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Gabrielli","sequence":"additional","affiliation":[{"name":"ASUR Marche - Area Vasta 4 Fermo, Ospedale Civile Augusto Murri, Fermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Geraci","sequence":"additional","affiliation":[{"name":"U.O.C. Cardiologia Azienda Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio Gaetano","family":"La Manna","sequence":"additional","affiliation":[{"name":"Divisione di Cardiologia A.O.U. Policlinico Vittorio Emanuele, Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo Pietro","family":"Maggioni","sequence":"additional","affiliation":[{"name":"Centro Studi ANMCO della Fondazione per il Tuo Cuore, Firenze, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Marchese","sequence":"additional","affiliation":[{"name":"GVM Care & Research Ospedale Santa Maria, Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdinando Maria","family":"Massari","sequence":"additional","affiliation":[{"name":"U.O.C. Malattie Cardiovascolari \"Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Francesco","family":"Mureddu","sequence":"additional","affiliation":[{"name":"U.O.C. Cardiologia 2, Azienda Ospedaliera San Giovanni Addolorata, Roma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Musumeci","sequence":"additional","affiliation":[{"name":"S.C. Cardiologia A.S.O. Santa Croce e Carle, Cuneo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Nardi","sequence":"additional","affiliation":[{"name":"S.C. Cardiologia, Ospedale Santo Spirito, Casale Monferrato (AL), Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Vittorio","family":"Panno","sequence":"additional","affiliation":[{"name":"Convenzione USL 6, Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto Franco Enrico","family":"Pedretti","sequence":"additional","affiliation":[{"name":"Dipartimento di Cardiologia Riabilitativa, Istituti Clinici Scientifici Maugeri, IRCCS, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Piredda","sequence":"additional","affiliation":[{"name":"Centro Cardiotoracico, Divisione di Cardiologia, Istituto Clinico Sant'Ambrogio, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Pusineri","sequence":"additional","affiliation":[{"name":"U.O.C. di Cardiologia, Ospedale Civile di Vigevano, A.S.S.T., Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmine","family":"Riccio","sequence":"additional","affiliation":[{"name":"Prevenzione e Riabilitazione Cardiopatico, AZ. Ospedaliera S. Anna e S. Sebastiano, Caserta, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Rossini","sequence":"additional","affiliation":[{"name":"S.C. Cardiologia A.S.O. Santa Croce e Carle, Cuneo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fortunato Scotto","family":"di Uccio","sequence":"additional","affiliation":[{"name":"Ospedale Loreto Mare, ASL NA 1, Napoli, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Urbinati","sequence":"additional","affiliation":[{"name":"U.O.C. Cardiologia, Ospedale Bellaria, AUSL di Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdinando","family":"Varbella","sequence":"additional","affiliation":[{"name":"S.C. Cardiologia, Ospedali Riuniti di Rivoli, Rivoli (TO), Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni Battista","family":"Zito","sequence":"additional","affiliation":[{"name":"Ambulatorio di Cardiologia, ASL Napoli 3 Sud, Pompei (NA), Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"De Luca","sequence":"additional","affiliation":[{"name":"U.O.C. Cardiologia, Ospedale San Giovanni Evangelista, Tivoli, Roma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"ESC Scientific Document Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto Maria","family":"Cappelletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavino","family":"Casu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Di Pasquale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Di Tano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Domenicucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina Maura","family":"Francese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Fresco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Franco","family":"Gensini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa La","family":"Rovere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana","family":"Luc\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciro","family":"Mauro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriano","family":"Murrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Rubboli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Giovanna","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Santomauro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corrado","family":"Tamburino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Tarantini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugo","family":"Vairo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guerrino","family":"Zuin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Faculty for approval of the Consensus Document","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio Giuseppe","family":"Abrignani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Ambrosetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Francesco","family":"Amico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Aspromonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Aulitto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Barile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacinto","family":"Calculli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Caldarola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Caporale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto Maria","family":"Cappelletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Carbonaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Casolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavino","family":"Casu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Cavallini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Chiuini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Furio","family":"Colivicchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Di Lenarda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Di Pasquale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Di Tano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Domenicucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pompilio","family":"Faggiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina Maura","family":"Francese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Fresco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Gabrielli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Franco","family":"Gensini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Geraci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loreto","family":"Gesualdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Giubilato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele Massimo","family":"Gulizia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio Gaetano","family":"La Manna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa","family":"La Rovere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana","family":"Luc\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo Pietro","family":"Maggioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Marchese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdinando Maria","family":"Massari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciro","family":"Mauro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Menozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Francesco","family":"Mureddu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriano","family":"Murrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Musumeci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Nardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Noussan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Vittorio","family":"Panno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Parodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto Franco Enrico","family":"Pedretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Piero","family":"Perna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Piredda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Pusineri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmine","family":"Riccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Rossini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Rubboli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Giovanna","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Saia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Santomauro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marino","family":"Scherillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giampaolo","family":"Scorcu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fortunato Scotto","family":"di Uccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corrado","family":"Tamburino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Tarantini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Urbinati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugo","family":"Vairo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdinando","family":"Varbella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni Battista","family":"Zito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guerrino","family":"Zuin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,5,31]]},"reference":[{"key":"key\n\t\t\t\t20180531030839_suy019-B1","author":"EpiCentro"},{"key":"key\n\t\t\t\t20180531030839_suy019-B2"},{"key":"key\n\t\t\t\t20180531030839_suy019-B3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/2047487315589011","article-title":"Cardiovascular health in Italy. Ten-year surveillance of cardiovascular diseases and risk factors: Osservatorio Epidemiologico Cardiovascolare\/Health Examination Survey 1998-2012","volume":"22(2 Suppl)","author":"Giampaoli","year":"2015","journal-title":"Eur J Prev Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B4","first-page":"7S","article-title":"La salute cardiovascolare degli italiani. Terzo Atlante Italiano delle Malattie Cardiovascolari - Edizione 2014","volume":"15(4 Suppl 1)","author":"Giampaoli","year":"2014","journal-title":"G Ital Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B5","first-page":"439","article-title":"Lo studio Mattone Outcome-BYPASS: sopravvivenza a breve termine in pazienti sottoposti a intervento di bypass aortocoronarico nelle cardiochirurgie italiane. Risultati finali","volume":"12","author":"Seccareccia","year":"2011","journal-title":"G Ital Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B6","doi-asserted-by":"crossref","first-page":"e356","DOI":"10.1136\/bmj.e356","article-title":"25 year trends in first time hospitalisation for acute myocardial infarction, subsequent short and long term mortality, and the prognostic impact of sex and comorbidity: a Danish nationwide cohort study","volume":"344","author":"Schmidt","year":"2012","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20180531030839_suy019-B7","first-page":"3S","article-title":"Documento ANMCO\/GICR-IACPR\/GISE: L\u2019organizzazione dell\u2019assistenza nella fase post-acuta delle sindromi coronariche","volume":"15(1 Suppl 1)","author":"Greco","year":"2014","journal-title":"G Ital Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B8","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1161\/CIRCOUTCOMES.110.957803","article-title":"Trends in mortality of acute myocardial infarction after discharge from the hospital","volume":"3","author":"Kostis","year":"2010","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"key\n\t\t\t\t20180531030839_suy019-B9","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ijcard.2015.01.073","article-title":"Trends in mortality and heart failure after acute myocardial infarction in Italy from 2001 to 2011","volume":"184","author":"Greco","year":"2015","journal-title":"Int J Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B10","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1409312","article-title":"Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents","volume":"371","author":"Mauri","year":"2014","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180531030839_suy019-B11","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1056\/NEJMoa1500857","article-title":"Long-term use of ticagrelor in patients with prior myocardial infarction","volume":"372","author":"Bonaca","year":"2015","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180531030839_suy019-B12","author":"World Heart Federation","year":"2014"},{"key":"key\n\t\t\t\t20180531030839_suy019-B13","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.ijcard.2012.04.069","article-title":"Effective secondary prevention through cardiac rehabilitation after coronary revascularization and predictors of poor adherence to lifestyle modification and medication. Results of the ICAROS Survey","volume":"167","author":"Griffo","year":"2013","journal-title":"Int J Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B14","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1001\/archinte.168.20.2194","article-title":"Global secondary prevention strategies to limit event recurrence after myocardial infarction: results of the GOSPEL study, a multicenter, randomized controlled trial from the Italian Cardiac Rehabilitation Network","volume":"168","author":"Giannuzzi","year":"2008","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t20180531030839_suy019-B15","first-page":"529","article-title":"Documento di consenso ANMCO\/GICR-IACPR\/SICI-GISE: La gestione clinica del paziente con cardiopatia ischemica cronica","volume":"17","author":"Riccio","year":"2016","journal-title":"G Ital Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B16","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S0735-1097(97)00213-1","article-title":"Pathology of unstable plaque: correlation with the clinical severity of acute coronary syndromes","volume":"30","author":"Depr\u00e9","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B17","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1093\/eurheartj\/eht296","article-title":"2013 ESC guidelines on the management of stable coronary artery disease. The Task Force on the management of stable coronary artery disease of the European Society of Cardiology","volume":"34","author":"Montalescot","year":"2013","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180531030839_suy019-B18","first-page":"225","article-title":"Assessment of activity status and survival according to the Canadian Cardiovascular Society angina classification. Can","volume":"25","author":"Kaul","year":"2009","journal-title":"J Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B19","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ahj.2010.09.018","article-title":"Prognostic value of sensitive troponin T in patients with stable and unstable angina and undetectable conventional troponin","volume":"161","author":"Ndrepepa","year":"2011","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t20180531030839_suy019-B20","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1056\/NEJMoa0805299","article-title":"A sensitive cardiac troponin T assay in stable coronary artery disease","volume":"361","author":"Omland","year":"2009","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180531030839_suy019-B21","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1093\/eurheartj\/ehp266","article-title":"The unstable plaque: a broken balance","volume":"30","author":"Crea","year":"2009","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180531030839_suy019-B22","first-page":"1222","volume-title":"Braunwald\u2019s Heart Disease: A Texbook of Cardiovascular Medicine. IX ed. Traduzione italiana","author":"Cannon","year":"2012"},{"key":"key\n\t\t\t\t20180531030839_suy019-B23","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","article-title":"ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)","volume":"37","author":"Roffi","year":"2016","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180531030839_suy019-B24","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1093\/eurheartj\/ehs184","article-title":"Third universal definition of myocardial infarction","volume":"33","author":"Thygesen","year":"2012","journal-title":"Eur Herat J"},{"key":"key\n\t\t\t\t20180531030839_suy019-B25","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1161\/CIRCULATIONAHA.113.001258","article-title":"Unstable angina: is it time for a requiem?","volume":"127","author":"Braunwald","year":"2013","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180531030839_suy019-B26","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1093\/eurheartj\/eht530","article-title":"Biomarkers and acute coronary syndromes: an update","volume":"35","author":"Mueller","year":"2014","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180531030839_suy019-B27","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.amjmed.2012.07.015","article-title":"Introduction of high-sensitivity troponin assays: impact on myocardial infarction incidence and prognosis","volume":"125","author":"Reichlin","year":"2012","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t20180531030839_suy019-B28","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/nm.2515","article-title":"Arterial thrombosis \u2013 insidious, unpredictable and deadly","volume":"17","author":"Jackson","year":"2011","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t20180531030839_suy019-B29","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1161\/CIRCRESAHA.113.300512","article-title":"Platelets as cellular effectors of inflammation in vascular diseases","volume":"112","author":"Rondina","year":"2013","journal-title":"Circ Res"},{"key":"key\n\t\t\t\t20180531030839_suy019-B30","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","author":"Antithrombotic Trialists\u2019 Collaboration","year":"2002","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20180531030839_suy019-B31","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)","volume":"348","author":"CAPRIE Steering Committee","year":"1996","journal-title":"Lancet"},{"issue":"4","key":"key\n\t\t\t\t20180531030839_suy019-B32","first-page":"CD001246","article-title":"Thienopyridine derivatives versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients","author":"Sudlow","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t20180531030839_suy019-B33","doi-asserted-by":"crossref","first-page":"NP1","DOI":"10.1177\/2047487316653709","article-title":"2016 European guidelines on cardiovascular disease prevention: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 society and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)","volume":"23","author":"Piepoli","year":"2016","journal-title":"Eur J Prev Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B34","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1161\/CIRCULATIONAHA.109.853069","article-title":"New P2Y12 inhibitors","volume":"121","author":"Cattaneo","year":"2010","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180531030839_suy019-B35","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa060989","article-title":"Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events","volume":"354","author":"Bhatt","year":"2006","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180531030839_suy019-B36","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.jacc.2007.03.025","article-title":"Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial","volume":"49","author":"Bhatt","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B37","first-page":"390","article-title":"Long-term dual antiplatelet therapy for secondary prevention of cardiovascular events in the subgroup of patients with previous myocardial infarction: a collaborative meta-analysis of randomized trials","volume":"37","author":"Udell","year":"2016","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180531030839_suy019-B38","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMra071014","article-title":"Platelet activation and atherothrombosis","volume":"357","author":"Dav\u00ec","year":"2007","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180531030839_suy019-B39","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1160\/TH09-03-0192","article-title":"Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis","volume":"102","author":"Jennings","year":"2009","journal-title":"Thromb Haemost"},{"key":"key\n\t\t\t\t20180531030839_suy019-B40","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1160\/TH07-11-0673","article-title":"P2 receptors, platelet function and pharmacological implications","volume":"99","author":"Gachet","year":"2008","journal-title":"Thromb Haemost"},{"key":"key\n\t\t\t\t20180531030839_suy019-B41","first-page":"19","article-title":"Roles of prostanoids in the pathogenesis on cardiovascular diseases","volume":"29","author":"Yuhky","year":"2010","journal-title":"Int Angiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B42","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/MOL.0b013e3282ef7c1e","article-title":"Molecular pathways used by platelets to initiate and accelerate atherogenesis","volume":"18","author":"Lindermann","year":"2007","journal-title":"Curr Opin Lipidol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B43","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials","volume":"373","author":"Baigent","year":"2009","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180531030839_suy019-B44","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ahj.2017.12.006","article-title":"ASCEND: A Study of Cardiovascular Events in Diabetes: characteristics of a randomized trial of aspirin and of omega-3 fatty acid supplementation in 15,480 people with diabetes","volume":"198","author":"Bowman","year":"2018","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t20180531030839_suy019-B45","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1745-6215-8-21","article-title":"Aspirin and Simvastatin Combination for Cardiovascular Events Prevention Trial in Diabetes (ACCEPT-D): design of a randomised study of the efficacy of low-dose aspirin in the prevention of cardiovascular events in subjects with diabetes mellitus treated with statins","volume":"8","author":"De Berardis","year":"2007","journal-title":"Trials"},{"key":"key\n\t\t\t\t20180531030839_suy019-B46","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1161\/CIRCULATIONAHA.109.853085","article-title":"Combination antithrombotic therapies","volume":"121","author":"Gurbel","year":"2010","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180531030839_suy019-B47","first-page":"29","article-title":"Pharmacokinetic profile of 14C-labeled clopidogrel","volume":"25 Suppl 2","author":"Lins","year":"1999","journal-title":"Semin Thromb Hemost"},{"key":"key\n\t\t\t\t20180531030839_suy019-B48","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1016\/S0049-3848(11)70017-2","article-title":"Resistance to anti-platelet agents","volume":"127 Suppl 3","author":"Cattaneo","year":"2011","journal-title":"Thromb Res"},{"key":"key\n\t\t\t\t20180531030839_suy019-B49","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180531030839_suy019-B50","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1001\/jama.288.19.2411","article-title":"Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial","volume":"288","author":"Steinhubl","year":"2002","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20180531030839_suy019-B51","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(01)05701-4","article-title":"Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study","volume":"358","author":"Mehta","year":"2001","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180531030839_suy019-B52","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0140-6736(05)67660-X","article-title":"Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial","volume":"366","author":"Chen","year":"2005","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180531030839_suy019-B53","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.jvs.2009.06.023","article-title":"Current evidence and clinical implications of aspirin resistance","volume":"50","author":"Kasotakis","year":"2009","journal-title":"J Vasc Surg"},{"key":"key\n\t\t\t\t20180531030839_suy019-B54","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1161\/01.CIR.0000072771.11429.83","article-title":"Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity","volume":"107","author":"Gurbel","year":"2003","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180531030839_suy019-B55","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/j.jacc.2005.07.056","article-title":"Clopidogrel effect on platelet reactivity in patients with stent thrombosis: results of the CREST Study","volume":"46","author":"Gurbel","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B56","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1093\/eurheartj\/ehs215","article-title":"ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation","volume":"33","author":"Steg","year":"2012","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180531030839_suy019-B57","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/eurheartj\/ehx419","article-title":"2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"39","author":"Valgimigli","year":"2018","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180531030839_suy019-B58","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1001\/jama.2009.261","article-title":"Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome","volume":"301","author":"Ho","year":"2009","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20180531030839_suy019-B59","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1503\/cmaj.082001","article-title":"A population-based study of the drug interaction between proton pump inhibitors and clopidogrel","volume":"180","author":"Juurlink","year":"2009","journal-title":"CMAJ"},{"key":"key\n\t\t\t\t20180531030839_suy019-B60","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1160\/TH08-12-0808","article-title":"Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel","volume":"101","author":"Sibbing","year":"2009","journal-title":"Thromb Haemost"},{"key":"key\n\t\t\t\t20180531030839_suy019-B61","doi-asserted-by":"crossref","first-page":"148.e1","DOI":"10.1016\/j.ahj.2008.09.017","article-title":"Effects of pantoprazole and esomeprazole on platelet inhibition by clopidogrel","volume":"157","author":"Siller-Matula","year":"2009","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t20180531030839_suy019-B62","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0140-6736(09)61525-7","article-title":"Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: analysis of two randomized trials","volume":"374","author":"O\u2019Donoghue","year":"2009","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180531030839_suy019-B63","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMoa1007964","article-title":"Clopidogrel with or without omeprazole in coronary artery disease","volume":"363","author":"Bhatt","year":"2010","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180531030839_suy019-B64","doi-asserted-by":"crossref","first-page":"e4388","DOI":"10.1136\/bmj.e4388","article-title":"Clopidogrel and interaction with proton pump inhibitors: comparison between cohort and within person study designs","volume":"345","author":"Douglas","year":"2012","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20180531030839_suy019-B65","first-page":"18","article-title":"Interazione tra clopidogrel e inibitori di pompa protonica","volume":"5","author":"Casula","year":"2013","journal-title":"Giornale Italiano di Farmacoeconomia e Farmacoutilizzazione"},{"key":"key\n\t\t\t\t20180531030839_suy019-B66","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jacc.2007.06.064","article-title":"Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole Clopidogrel Aspirin) study","volume":"51","author":"Gilard","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B67","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1253\/circj.CJ-12-0511","article-title":"Influence of omeprazole and famotidine on the antiplatelet effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes: a prospective, randomized, multicenter study","volume":"76","author":"Yano","year":"2012","journal-title":"Circ J"},{"key":"key\n\t\t\t\t20180531030839_suy019-B68","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1182\/blood-2006-04-013052","article-title":"Cytochrome P450 2C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjects","volume":"108","author":"Hulot","year":"2006","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180531030839_suy019-B69","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/35051599","article-title":"Identification of the platelet ADP receptor targeted by antithrombotic drugs","volume":"409","author":"Hollopeter","year":"2001","journal-title":"Nature"},{"key":"key\n\t\t\t\t20180531030839_suy019-B70","doi-asserted-by":"crossref","first-page":"e000248","DOI":"10.1136\/openhrt-2015-000248","article-title":"Incidence of cardiovascular events and gastrointestinal bleeding in patients receiving clopidogrel with and without proton pump inhibitors: an updated meta-analysis","volume":"2","author":"Cardoso","year":"2015","journal-title":"Open Heart"},{"key":"key\n\t\t\t\t20180531030839_suy019-B71","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-2005-869525","article-title":"Preclinical and clinical studies with selective reversible direct P2Y12 antagonists","volume":"31","author":"van Giezen","year":"2005","journal-title":"Semin Thromb Hemost"},{"key":"key\n\t\t\t\t20180531030839_suy019-B72","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/eurheartj\/ehi754","article-title":"Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin","volume":"27","author":"Husted","year":"2006","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180531030839_suy019-B73","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1016\/j.jacc.2007.07.058","article-title":"Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes","volume":"50","author":"Storey","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B74","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/sj.clpt.6100139","article-title":"Cytochrome P450 3A inhibition by ketoconazole affects prasugrel and clopidogrel pharmacokinetics and pharmacodynamics differently","volume":"81","author":"Farid","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"key\n\t\t\t\t20180531030839_suy019-B75","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1016\/j.jacc.2007.07.053","article-title":"Safety, tolerability, and initial efficacy of AZD6140, the first reversible oral adenosine diphosphate receptor antagonist, compared with clopidogrel, in patients with non-ST-segment elevation acute coronary syndrome: primary results of the DISPERSE-2 trial","volume":"50","author":"Cannon","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B76","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180531030839_suy019-B77","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","article-title":"2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180531030839_suy019-B78","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1093\/eurheartj\/ehp159","article-title":"Pharmacodynamic assessment of platelet inhibition by prasugrel vs. clopidogrel in the TRITON-TIMI 38 trial","volume":"30","author":"Michelson","year":"2009","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180531030839_suy019-B79","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1161\/CIRCULATIONAHA.104.502815","article-title":"Randomized comparison of prasugrel (CS-747, LY640315), a novel thienopyridine P2Y12 antagonist, with clopidogrel in percutaneous coronary intervention: results of the Joint Utilization of Medications to Block Platelets Optimally (JUMBO)-TIMI 26 trial","volume":"111","author":"Wiviott","year":"2005","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180531030839_suy019-B80","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1161\/CIRCULATIONAHA.107.740324","article-title":"Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myocardial Infarction 44 trial","volume":"116","author":"Wiviott","year":"2007","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180531030839_suy019-B81","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1527-3466.2007.00027.x","article-title":"Prasugrel: a novel thienopyridine antiplatelet agent. A review of preclinical and clinical studies and the mechanistic basis for its distinct antiplatelet profile","volume":"25","author":"Jakubowski","year":"2007","journal-title":"Cardiovasc Drug Rev"},{"key":"key\n\t\t\t\t20180531030839_suy019-B82","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1160\/TH09-07-0482","article-title":"Prasugrel compared with high-dose clopidogrel in acute coronary syndrome. The randomized, double-blind ACAPULCO study","volume":"103","author":"Montalescot","year":"2010","journal-title":"Thromb Haemost"},{"key":"key\n\t\t\t\t20180531030839_suy019-B83","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.jacc.2010.02.072","article-title":"Increased platelet inhibition after switching from maintenance clopidogrel to prasugrel in patients with acute coronary syndromes: results of the SWAP (SWitching Anti Platelet) study","volume":"56","author":"Angiolillo","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B84","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jcin.2010.12.011","article-title":"Prasugrel overcomes high on-clopidogrel platelet reactivity post-stenting more effectively than high-dose (150-mg) clopidogrel: the importance of CYP2C19*2 genotyping","volume":"4","author":"Alexopoulos","year":"2011","journal-title":"JACC Cardiovasc Interv"},{"key":"key\n\t\t\t\t20180531030839_suy019-B85","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180531030839_suy019-B86","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1161\/CIRCULATIONAHA.110.002683","article-title":"Predictors of bleeding and time dependence of association of bleeding with mortality: Insights from the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38 (TRITON-TIMI 38)","volume":"123","author":"Hochholzer","year":"2011","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180531030839_suy019-B87","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0140-6736(09)60441-4","article-title":"Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial","volume":"373","author":"Montalescot","year":"2009","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180531030839_suy019-B88","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1161\/CIRCULATIONAHA.108.791061","article-title":"Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocardial Infarction 38","volume":"118","author":"Wiviott","year":"2008","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180531030839_suy019-B89","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jacc.2012.03.030","article-title":"Mortality benefit with prasugrel in the TRITON-TIMI 38 coronary artery bypass grafting cohort: risk-adjusted retrospective data analysis","volume":"60","author":"Smith","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B90","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.jacc.2009.05.025","article-title":"The efficacy and safety of prasugrel with and without a glycoprotein IIb\/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) analysis","volume":"54","author":"O\u2019Donoghue","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B91","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1093\/eurheartj\/ehn362","article-title":"Reduction in recurrent cardiovascular events with prasugrel compared with clopidogrel in patients with acute coronary syndromes from the TRITON-TIMI 38 trial","volume":"29","author":"Murphy","year":"2008","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180531030839_suy019-B92","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.ahj.2009.06.021","article-title":"Effect of prasugrel versus clopidogrel on outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention without stent implantation: a TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet inhibitioN with prasugrel (TRITON)-Thrombolysis in Myocardial Infarction (TIMI) 38 substudy","volume":"158","author":"Pride","year":"2009","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t20180531030839_suy019-B93","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1056\/NEJMoa1205512","article-title":"Prasugrel versus clopidogrel for acute coronary syndromes without revascularization","volume":"367","author":"Roe","year":"2012","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180531030839_suy019-B94","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1056\/NEJMoa012843","article-title":"A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization","volume":"346","author":"Morice","year":"2002","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180531030839_suy019-B95","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1056\/NEJMoa035071","article-title":"Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery","volume":"349","author":"Moses","year":"2003","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180531030839_suy019-B96","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0140-6736(03)14462-5","article-title":"Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS)","volume":"362","author":"Schofer","year":"2003","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180531030839_suy019-B97","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.jacc.2004.01.024","article-title":"The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS)","volume":"43","author":"Schampaert","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B98","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1161\/01.CIR.0000047700.58683.A1","article-title":"TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions","volume":"107","author":"Grube","year":"2003","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180531030839_suy019-B99","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa032441","article-title":"A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease","volume":"350","author":"Stone","year":"2004","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180531030839_suy019-B100","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1161\/CIRCULATIONAHA.112.097014","article-title":"Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials","volume":"125","author":"Bangalore","year":"2012","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180531030839_suy019-B101","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1093\/eurheartj\/ehs036","article-title":"Comparison of drug-eluting stents with bare metal stents in patients with ST-segment elevation myocardial infarction","volume":"33","author":"Kalesan","year":"2012","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180531030839_suy019-B102","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1161\/CIRCULATIONAHA.104.532242","article-title":"Safety of coronary sirolimus-eluting stents in daily clinical practice: one-year follow-up of the e-Cypher registry","volume":"113","author":"Urban","year":"2006","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180531030839_suy019-B103","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1001\/jama.293.17.2109","article-title":"Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: a randomized trial","volume":"293","author":"Valgimigli","year":"2005","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20180531030839_suy019-B104","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1161\/CIRCULATIONAHA.105.600155","article-title":"Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents","volume":"113","author":"Kuchulakanti","year":"2006","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180531030839_suy019-B105","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.jacc.2004.12.066","article-title":"Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study","volume":"45","author":"Fujii","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B106","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.jacc.2005.05.080","article-title":"Contemporary stent treatment of coronary bifurcations","volume":"46","author":"Iakovou","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B107","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1001\/jama.297.2.joc60179","article-title":"Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation","volume":"297","author":"Eisenstein","year":"2007","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20180531030839_suy019-B108","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1477-9560-5-15","article-title":"Dual antiplatelet therapy and drug eluting stents: a marriage of convenience","volume":"5","author":"Benezet-Mazuecos","year":"2007","journal-title":"Thromb J"},{"key":"key\n\t\t\t\t20180531030839_suy019-B109","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jacc.2006.03.042","article-title":"Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk","volume":"48","author":"Joner","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B110","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/01.fjc.0000248233.22570.8b","article-title":"Effects of tacrolimus or sirolimus on proliferation of vascular smooth muscle and endothelial cells","volume":"48","author":"Matter","year":"2006","journal-title":"J Cardiovasc Pharmacol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B111","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ejphar.2005.09.042","article-title":"Drug-eluting stents: sirolimus and paclitaxel differentially affect cultured cells and injured arteries","volume":"524","author":"Parry","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B112","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1161\/01.CIR.0000091115.05480.B0","article-title":"Pathological mechanisms of fatal late coronary stent thrombosis in humans","volume":"108","author":"Farb","year":"2003","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180531030839_suy019-B113","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.jcin.2013.07.009","article-title":"5-year results of a randomized comparison of XIENCE V everolimus-eluting and TAXUS paclitaxel-eluting stents: final results from the SPIRIT III trial (clinical evaluation of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions)","volume":"6","author":"Gada","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"key":"key\n\t\t\t\t20180531030839_suy019-B114","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jcin.2013.04.011","article-title":"Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial","volume":"6","author":"Serruys","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"key":"key\n\t\t\t\t20180531030839_suy019-B115","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1093\/eurheartj\/ehu318","article-title":"Endeavour zotarolimus-eluting stent reduces stent thrombosis and improves clinical outcomes compared with cypher sirolimus-eluting stent: 4-year results of the PROTECT randomized trial","volume":"35","author":"Wijns","year":"2014","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180531030839_suy019-B116","doi-asserted-by":"crossref","first-page":"g6427","DOI":"10.1136\/bmj.g6427","article-title":"Effects of cobalt-chromium everolimus eluting stents or bare metal stent on fatal and non-fatal cardiovascular events: patient level meta-analysis","volume":"349","author":"Valgimigli","year":"2014","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20180531030839_suy019-B117","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1093\/eurheartj\/ehs460","article-title":"Should duration of dual antiplatelet therapy depend on the type and\/or potency of implanted stent? A pre-specified analysis from the PROlonging Dual antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY (PRODIGY)","volume":"34","author":"Valgimigli","year":"2013","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180531030839_suy019-B118","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jcin.2013.09.008","article-title":"Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplasia studY)","volume":"7","author":"Valgimigli","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"key":"key\n\t\t\t\t20180531030839_suy019-B119","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.ahj.2010.07.034","article-title":"Randomized comparison of 6- versus 24-month clopidogrel therapy after balancing anti-intimal hyperplasia stent potency in all-comer patients undergoing percutaneous coronary intervention Design and rationale for the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia study (PRODIGY)","volume":"160","author":"Valgimigli","year":"2010","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t20180531030839_suy019-B120","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1056\/NEJMoa1607991","article-title":"Drug-eluting or bare-metal stents for coronary artery disease","volume":"375","author":"Bonaa","year":"2016","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180531030839_suy019-B121","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/j.jcin.2015.05.026","article-title":"Stent thrombosis in drug-eluting or bare-metal stents in patients receiving dual antiplatelet therapy","volume":"8","author":"Kereiakes","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"key\n\t\t\t\t20180531030839_suy019-B122","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jcin.2015.09.024","article-title":"Scaffold thrombosis after percutaneous coronary intervention with ABSORB bioresorbable vascular scaffold: a systematic review and meta-analysis","volume":"9","author":"Lipinski","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"key\n\t\t\t\t20180531030839_suy019-B123","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.ijcard.2016.07.101","article-title":"Safety and efficacy of everolimus-eluting bioresorbable vascular scaffolds versus durable polymer everolimus-eluting metallic stents assessed at 1-year follow-up: a systematic review and meta-analysis of studies","volume":"221","author":"Mukete","year":"2016","journal-title":"Int J Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B124","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1093\/eurheartj\/ehu278","article-title":"2014 ESC\/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI)","volume":"35","author":"Windecker","year":"2014","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180531030839_suy019-B125","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jacc.2016.03.513","article-title":"2016 ACC\/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"68","author":"Levine","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B126","author":"National Institute for Health and Care Experience (NICE)","year":"14 2016"},{"key":"key\n\t\t\t\t20180531030839_suy019-B127","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.amjmed.2012.01.014","article-title":"An international model to predict recurrent cardiovascular disease","volume":"125","author":"Wilson","year":"2012","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t20180531030839_suy019-B128","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/hrt.2004.057703","article-title":"Favourable long term prognosis in stable angina pectoris: an extended follow up of the Angina Prognosis Study in Stockholm (APSIS)","volume":"92","author":"Hjemdahl","year":"2006","journal-title":"Heart"},{"key":"key\n\t\t\t\t20180531030839_suy019-B129","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1016\/S0140-6736(09)61751-7","article-title":"Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data","volume":"374","author":"Sorensen","year":"2009","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180531030839_suy019-B130","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1161\/CIRCULATIONAHA.113.004747","article-title":"Risk of lower and upper gastrointestinal bleeding, transfusions, and hospitalizations with complex antithrombotic therapy in elderly patients","volume":"128","author":"Abraham","year":"2013","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180531030839_suy019-B131","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1161\/CIRCULATIONAHA.112.114967","article-title":"Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort study","volume":"126","author":"Lamberts","year":"2012","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180531030839_suy019-B132","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1253\/circj.CJ-12-1177","article-title":"Simple risk algorithm to predict serious bleeding in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: RISK-PCI bleeding score","volume":"77","author":"Mrdovic","year":"2013","journal-title":"Circ J"},{"key":"key\n\t\t\t\t20180531030839_suy019-B133","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS: The Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180531030839_suy019-B134","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1001\/jamacardio.2016.2110","article-title":"Antiplatelet therapy for long-term secondary prevention after myocardial infarction","volume":"1","author":"Bonaca","year":"2016","journal-title":"JAMA Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B135","first-page":"e29","article-title":"Heart disease and stroke statistics \u2013 2015 update: a report from the American Heart Association","volume":"131","author":"Mozaffarian","year":"2015","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180531030839_suy019-B136","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1001\/jama.2010.1322","article-title":"Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis","volume":"304","author":"Bhatt","year":"2010","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20180531030839_suy019-B137","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1093\/eurheartj\/ehq326","article-title":"Underestimated and under-recognized: the late consequences of acute coronary syndrome (GRACE UK-Belgian Study)","volume":"31","author":"Fox","year":"2010","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180531030839_suy019-B138","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1093\/eurheartj\/ehu505","article-title":"Cardiovascular risk in post-myocardial infarction patients: nationwide real world data demonstrate the importance of a long-term perspective","volume":"36","author":"Jernberg","year":"2015","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180531030839_suy019-B139","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1056\/NEJMoa1002358","article-title":"A prospective natural-history study of coronary atherosclerosis","volume":"364","author":"Stone","year":"2011","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180531030839_suy019-B140","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1161\/CIRCULATIONAHA.109.895342","article-title":"Bleeding complications with dual antiplatelet therapy among patients with stable vascular disease or risk factors for vascular disease: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial","volume":"121","author":"Berger","year":"2010","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180531030839_suy019-B141","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1001\/jamainternmed.2014.5802","article-title":"Secondary prevention of cardiovascular disease with vorapaxar: a new era of 3-drug antiplatelet therapy?","volume":"175","author":"Krantz","year":"2015","journal-title":"JAMA Intern Med"},{"key":"key\n\t\t\t\t20180531030839_suy019-B142","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1056\/NEJMoa1200933","article-title":"Vorapaxar in the secondary prevention of atherothrombotic events","volume":"366","author":"Morrow","year":"2012","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180531030839_suy019-B143","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/S0140-6736(12)61269-0","article-title":"Vorapaxar for secondary prevention of thrombotic events for patients with previous myocardial infarction: a prespecified subgroup analysis of the TRA 2\u00b0P-TIMI 50 trial","volume":"380","author":"Scirica","year":"2012","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180531030839_suy019-B144","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1161\/CIRCULATIONAHA.114.013774","article-title":"Vorapaxar in patients with diabetes mellitus and previous myocardial infarction: findings from the thrombin receptor antagonist in secondary prevention of atherothrombotic ischemic events-TIMI 50 trial","volume":"131","author":"Cavender","year":"2015","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180531030839_suy019-B145","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.ahj.2013.12.020","article-title":"Design and rationale for the Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-Thrombolysis in Myocardial Infarction 54 (PEGASUS-TIMI 54) trial","volume":"167","author":"Bonaca","year":"2014","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t20180531030839_suy019-B146","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1093\/eurheartj\/ehv531","article-title":"Ischaemic risk and efficacy of ticagrelor in relation to time from P2Y12 inhibitor withdrawal in patients with prior myocardial infarction: insights from PEGASUS-TIMI 54","volume":"37","author":"Bonaca","year":"2016","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180531030839_suy019-B147","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1001\/jamacardio.2016.1017","article-title":"Long-term tolerability of ticagrelor for the secondary prevention of major adverse cardiovascular events: a secondary analysis of the PEGASUS-TIMI 54 trial","volume":"1","author":"Bonaca","year":"2016","journal-title":"JAMA Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B148","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.jacc.2017.07.768","article-title":"Efficacy and safety of ticagrelor over time in patients with prior MI in PEGASUS-TIMI 54","volume":"70","author":"Bonaca","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B149","first-page":"794","article-title":"Efficacy and safety with ticagrelor in patients with prior myocardial infarction in the approved European label: insights from PEGASUS-TIMI 54 [abstract]","volume":"38(Suppl)","author":"Dellborg","year":"2017","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180531030839_suy019-B150","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1136\/heartjnl-2016-309509","article-title":"International patterns of dual antiplatelet therapy duration after acute coronary syndromes","volume":"103","author":"Bueno","year":"2017","journal-title":"Heart"},{"key":"key\n\t\t\t\t20180531030839_suy019-B151","first-page":"3S","article-title":"Il ruolo dell\u2019aderenza al trattamento farmacologico nella terapia cronica delle malattie cardiovascolari: documento intersocietario di consenso","volume":"15(Suppl 1)","author":"Volpe","year":"2014","journal-title":"G Ital Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B152","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1524-4733.2007.00213.x","article-title":"Medication compliance and persistence: terminology and definitions","volume":"11","author":"Cramer","year":"2008","journal-title":"Value Health"},{"key":"key\n\t\t\t\t20180531030839_suy019-B153","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.amjmed.2011.12.013","article-title":"Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients","volume":"125","author":"Naderi","year":"2012","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t20180531030839_suy019-B154","volume-title":"Adherence to long-term therapies: evidence for action","author":"Sabat\u00e9","year":"2003"},{"key":"key\n\t\t\t\t20180531030839_suy019-B155","doi-asserted-by":"crossref","first-page":"388","DOI":"10.2174\/1570161113666151030105805","article-title":"Impact of polypharmacy on adherence to evidence-based medication in patients who underwent percutaneous coronary intervention","volume":"14","author":"Mohammed","year":"2016","journal-title":"Curr Vasc Pharmacol."},{"key":"key\n\t\t\t\t20180531030839_suy019-B156","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.jcin.2016.04.004","article-title":"Sex-based differences in cessation of dual-antiplatelet therapy following percutaneous coronary intervention with stents","volume":"9","author":"Yu","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"key\n\t\t\t\t20180531030839_suy019-B157","doi-asserted-by":"crossref","first-page":"230","DOI":"10.2459\/JCM.0000000000000070","article-title":"Adherence to antiplatelet therapy after percutaneous coronary intervention: a population study in a region of Italy","volume":"16","author":"Pinnarelli","year":"2015","journal-title":"J Cardiovasc Med"},{"key":"key\n\t\t\t\t20180531030839_suy019-B158","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1097\/01.hco.0000409963.12964.7d","article-title":"Causes and clinical implications of premature discontinuation of dual antiplatelet therapy","volume":"26(Suppl 1)","author":"De Servi","year":"2011","journal-title":"Curr Opin Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B159","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1540-8183.2012.00746.x","article-title":"Safety of temporary and permanent suspension of antiplatelet therapy after drug eluting stent implantation in contemporary \u201creal-world\u201d practice","volume":"25","author":"Kovacic","year":"2012","journal-title":"J Interv Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B160","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/JCN.0b013e31825d6060","article-title":"Changing illness perceptions and adherence to dual antiplatelet therapy in patients with stable coronary disease","volume":"28","author":"Fennessy","year":"2013","journal-title":"J Cardiovasc Nurs"},{"key":"key\n\t\t\t\t20180531030839_suy019-B161","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/clc.22289","article-title":"Adherence to dual antiplatelet therapy after coronary stenting: a systematic review","volume":"37","author":"Czarny","year":"2014","journal-title":"Clin Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B162","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1136\/heartjnl-2012-303004","article-title":"Telephone contact to improve adherence to dual antiplatelet therapy after drug-eluting stent implantation","volume":"99","author":"Rinfret","year":"2013","journal-title":"Heart"},{"key":"key\n\t\t\t\t20180531030839_suy019-B163","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/S0140-6736(13)61720-1","article-title":"Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study","volume":"382","author":"Mehran","year":"2013","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180531030839_suy019-B164","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1001\/archinte.166.17.1842","article-title":"Impact of medication therapy discontinuation on mortality after myocardial infarction","volume":"166","author":"Ho","year":"2006","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t20180531030839_suy019-B165","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s10557-013-6455-z","article-title":"Outcomes, health costs and use of antiplatelet agents in 7082 patients admitted for an acute coronary syndrome occurring in a large community setting","volume":"27","author":"Maggioni","year":"2013","journal-title":"Cardiovasc Drugs Ther"},{"key":"key\n\t\t\t\t20180531030839_suy019-B166","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1161\/CIRCULATIONAHA.106.618066","article-title":"Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry","volume":"113","author":"Spertus","year":"2006","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180531030839_suy019-B167","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.amjcard.2008.11.038","article-title":"Temporal relation between clopidogrel cessation and stent thrombosis after drug-eluting stent implantation","volume":"103","author":"Roy","year":"2009","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B168","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehr236","article-title":"ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)","volume":"32","author":"Hamm","year":"2011","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180531030839_suy019-B169","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jacc.2012.06.004","article-title":"2012 ACCF\/AHA focused update of the guideline for the management of patients with unstable angina\/non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"60","author":"Kneid","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B170","first-page":"485","article-title":"2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"61","author":"O\u2019Gara","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B171","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ahj.2016.03.006","article-title":"Switching of platelet P2Y12 receptor inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention: review of the literature and practical considerations","volume":"176","author":"De Luca","year":"2016","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t20180531030839_suy019-B172","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ahj.2013.10.010","article-title":"In-hospital switching of oral P2Y12 inhibitor treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention: prevalence, predictors and short-term outcome","volume":"167","author":"Alexopoulos","year":"2014","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t20180531030839_suy019-B173","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1177\/2048872614560505","article-title":"Contemporary antithrombotic strategies in patients with acute coronary syndrome admitted to cardiac care units in Italy: The EYESHOT Study","volume":"4","author":"De Luca","year":"2015","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"key\n\t\t\t\t20180531030839_suy019-B174","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/ehjcvp\/pvw003","article-title":"Use, patient selection and outcomes of P2Y12 receptor inhibitor treatment in patients with STEMI based on contemporary European registries","volume":"2","author":"Danchin","year":"2016","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"key\n\t\t\t\t20180531030839_suy019-B175","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/ehjcvp\/pvw005","article-title":"P2Y12 receptor inhibitors in patients with non-ST-elevation acute coronary syndrome in the real world: use, patient selection, and outcomes from contemporary European registries","volume":"2","author":"Zeymer","year":"2016","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"key\n\t\t\t\t20180531030839_suy019-B176","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ahj.2016.10.006","article-title":"Switching of adenosine diphosphate receptor inhibitor after hospital discharge among myocardial infarction patients: insights from the Treatment with Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) observational study","volume":"183","author":"Zettler","year":"2017","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t20180531030839_suy019-B177","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1161\/CIRCULATIONAHA.109.919456","article-title":"Response to ticagrelor in clopidogrel non-responders and responders and effect of switching therapies. The RESPOND study","volume":"121","author":"Gurbel","year":"2010","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180531030839_suy019-B178","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1161\/CIRCINTERVENTIONS.113.000512","article-title":"Administration of a loading dose has no additive effect on platelet aggregation during the switch from ongoing clopidogrel treatment to ticagrelor in patients with acute coronary syndrome","volume":"7","author":"Caiazzo","year":"2014","journal-title":"Circ Cardiovasc Interv"},{"key":"key\n\t\t\t\t20180531030839_suy019-B179","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrcardio.2015.113","article-title":"Switching P2Y12-receptor inhibitors in patients with coronary artery disease","volume":"13","author":"Rollini","year":"2016","journal-title":"Nat Rev Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B180","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1161\/CIRCINTERVENTIONS.112.000063","article-title":"Effect on platelet reactivity from a prasugrel loading dose after a clopidogrel loading dose compared with a prasugrel loading dose alone: Transferring From Clopidogrel Loading Dose to Prasugrel Loading Dose in Acute Coronary Syndrome Patients (TRIPLET): a randomized controlled trial","volume":"6","author":"Diodati","year":"2013","journal-title":"Circ Cardiovasc Interv"},{"key":"key\n\t\t\t\t20180531030839_suy019-B181","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jcin.2012.09.012","article-title":"Switching acute coronary syndrome patients from prasugrel to clopidogrel","volume":"6","author":"Kerneis","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"key":"key\n\t\t\t\t20180531030839_suy019-B182","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jcin.2012.12.001","article-title":"Switching from prasugrel to clopidogrel: navigating in unknown waters","volume":"6","author":"Angiolillo","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"key":"key\n\t\t\t\t20180531030839_suy019-B183","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.jacc.2013.11.032","article-title":"Pharmacodynamic evaluation of switching from ticagrelor to prasugrel in subjects with stable coronary artery disease: results of the SWAP-2 study (Switching Anti Platelet-2)","volume":"63","author":"Angiolillo","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B184","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.ijcard.2014.07.123","article-title":"Switching from ticagrelor to prasugrel: a warning","volume":"176","author":"Parodi","year":"2014","journal-title":"Int J Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B185","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.ijcard.2014.07.216","article-title":"First report of stent thrombosis after a switch therapy resulting from ticagrelor-related dyspnea","volume":"176","author":"Wu","year":"2014","journal-title":"Int J Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B186","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1093\/eurheartj\/ehr373","article-title":"Antiplatelet agents for the treatment and prevention of atherothrombosis","volume":"32","author":"Patrono","year":"2011","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180531030839_suy019-B187","first-page":"462","article-title":"Documento di consenso ANMCO\/SIC\/SICI-GISE\/SICCH: Approccio clinico al pretrattamento farmacologico in pazienti candidati a procedure di rivascolarizzazione miocardica","volume":"17","author":"Caporale","year":"2016","journal-title":"G Ital Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B188","doi-asserted-by":"crossref","first-page":"38","DOI":"10.4244\/EIJV10I1A8","article-title":"Perioperative management of antiplatelet therapy in patients with coronary stents undergoing cardiac and non-cardiac surgery: a consensus document from Italian cardiological, surgical and anaesthesiological societies","volume":"10","author":"Rossini","year":"2014","journal-title":"EuroIntervention"},{"key":"key\n\t\t\t\t20180531030839_suy019-B189","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.jacc.2014.12.046","article-title":"Short- versus long-term dual antiplatelet therapy after drug-eluting stent implantation: an individual patient data pairwise and network meta-analysis","volume":"65","author":"Palmerini","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B190","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1016\/j.jacc.2014.09.008","article-title":"Second-generation drug-eluting stent implantation followed by 6- versus 12-month dual antiplatelet therapy: the SECURITY randomized clinical trial","volume":"64","author":"Colombo","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B191","first-page":"28S","article-title":"Documento di posizione SICI-GISE: Utilizzo di Absorb BVS nella pratica clinica","volume":"17(10 Suppl 1)","author":"Tarantini","year":"2016","journal-title":"G Ital Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B192","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jacc.2015.05.053","article-title":"Duration of dual antiplatelet therapy after coronary stenting a review of the evidence","volume":"66","author":"Montalescot","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B193","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.jacc.2012.02.026","article-title":"A randomized trial of prasugrel versus clopidogrel in patients with high platelet reactivity on clopidogrel after elective percutaneous coronary intervention with implantation of drug-eluting stents: results of the TRIGGER-PCI (Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel) study","volume":"59","author":"Trenk","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B194","first-page":"549","article-title":"The efficacy and safety of ticagrelor in women versus men with a prior myocardial infarction: insights from the PEGASUS-TIMI 54 trial [abstract]","volume":"36(Suppl 1)","author":"O\u2019Donogue","year":"2015","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180531030839_suy019-B195","first-page":"549","article-title":"Ticagrelor 60 mg twice-daily provides effective platelet inhibition in patients with prior myocardial infarction: the PEGASUS-TIMI 54 platelet function substudy [abstract]","volume":"36 (Suppl1)","author":"Storey","year":"2015","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180531030839_suy019-B196","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1161\/01.CIR.91.6.1676","article-title":"Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance","volume":"91","author":"Colombo","year":"1995","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180531030839_suy019-B197","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1056\/NEJM199604253341702","article-title":"A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents","volume":"334","author":"Sch\u00f6mig","year":"1996","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180531030839_suy019-B198","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1056\/NEJM199812033392303","article-title":"A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators","volume":"339","author":"Leon","year":"1998","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180531030839_suy019-B199","volume-title":"Ottimizzazione della terapia antiaggregante nelle sindromi coronariche acute","author":"Varbella","year":"2016"},{"key":"key\n\t\t\t\t20180531030839_suy019-B200","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1056\/NEJMoa050522","article-title":"Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation","volume":"352","author":"Sabatine","year":"2005","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180531030839_suy019-B201","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1056\/NEJMoa0909475","article-title":"Dose comparisons of clopidogrel and aspirin in acute coronary syndromes","volume":"363","author":"Mehta","year":"2010","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180531030839_suy019-B202","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0140-6736(15)60213-6","article-title":"Clinical evidence for oral antiplatelet therapy in acute coronary syndromes","volume":"386","author":"Wiviott","year":"2015","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180531030839_suy019-B203","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0140-6736(09)62191-7","article-title":"Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study","volume":"375","author":"Cannon","year":"2010","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180531030839_suy019-B204","first-page":"344","article-title":"Oral dual antiplatelet therapy: what have we learnt from recent trials?","volume":"37","author":"Montalescot","year":"2016","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180531030839_suy019-B205","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1161\/CIRCULATIONAHA.111.071589","article-title":"Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial","volume":"125","author":"Valgimigli","year":"2012","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180531030839_suy019-B206","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.jacc.2012.06.043","article-title":"A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation)","author":"Kim","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B207","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1161\/CIRCULATIONAHA.111.059022","article-title":"Six-month versus 12-month dual antiplatelet therapy after implantation of drug eluting stents: the Efficacy of Xience\/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) randomized, multicenter study","volume":"125","author":"Gwon","year":"2012","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180531030839_suy019-B208","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1016\/j.jacc.2015.03.003","article-title":"Benefits and risks of extended duration dual antiplatelet therapy after PCI in patients with and without acute myocardial infarction","volume":"65","author":"Yeh","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B209","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1001\/jama.2016.3775","article-title":"Development and validation of a prediction rule for benefit and harm of dual antiplatelet therapy beyond 1 year after percutaneous coronary intervention","volume":"315","author":"Yeh","year":"2016","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20180531030839_suy019-B210","first-page":"365","article-title":"Stopping or continuing clopidogrel 12 months after drug-eluting stent placement: the OPTIDUAL randomized trial","volume":"37","author":"Helft","year":"2016","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180531030839_suy019-B211","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1161\/CIRCULATIONAHA.113.003303","article-title":"Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: a randomized, controlled trial","volume":"129","author":"Lee","year":"2014","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180531030839_suy019-B212","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(14)60612-7","article-title":"Dual-antiplatelet treatment beyond 1 year after drug-eluting stent implantation (ARCTIC-Interruption): a randomised trial","volume":"384","author":"Collet","year":"2014","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180531030839_suy019-B213","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/j.jacc.2016.07.760","article-title":"Efficacy and safety of dual antiplatelet therapy after complex PCI","volume":"68","author":"Giustino","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B214","doi-asserted-by":"crossref","first-page":"e1222","DOI":"10.4244\/EIJY15M08_04","article-title":"Left main or proximal left anterior descending coronary artery disease location identifies high-risk patients deriving potentially greater benefit from prolonged dual antiplatelet therapy duration","volume":"11","author":"Costa","year":"2016","journal-title":"EuroIntervention"},{"key":"key\n\t\t\t\t20180531030839_suy019-B215","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S0140-6736(17)30397-5","article-title":"Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials","volume":"389","author":"Costa","year":"2017","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180531030839_suy019-B216","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1056\/NEJMoa1503943","article-title":"Polymer-free drug-coated coronary stents in patients at high bleeding risk","volume":"373","author":"Urban","year":"2015","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180531030839_suy019-B217","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1093\/eurheartj\/ehs367","article-title":"Incidence and multivariable correlates of long-term mortality in patients treated with surgical or percutaneous revascularization in the Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery (SYNTAX) trial","volume":"33","author":"Farooq","year":"2012","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180531030839_suy019-B218","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/0002-8703(92)90496-I","article-title":"Aspirin use and survival after coronary bypass surgery","volume":"123","author":"Johnson","year":"1992","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t20180531030839_suy019-B219","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1056\/NEJM198207083070201","article-title":"A platelet-inhibitor-drug trial in coronary-artery bypass operations: benefit of perioperative dipyridamole and aspirin therapy on early postoperative vein-graft patency","volume":"307","author":"Chesebro","year":"1982","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180531030839_suy019-B220","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJM198401263100401","article-title":"Effect of dipyridamole and aspirin on late vein-graft patency after coronary bypass operations","volume":"310","author":"Chesebro","year":"1984","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180531030839_suy019-B221","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1161\/01.CIR.77.6.1324","article-title":"Improvement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy: results of a Veterans Administration Cooperative Study","volume":"77","author":"Goldman","year":"1988","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180531030839_suy019-B222","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1161\/01.CIR.0000140675.85342.1B","article-title":"Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial","volume":"110","author":"Fox","year":"2004","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180531030839_suy019-B223","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.jacc.2010.09.069","article-title":"Efficacy of post-operative clopidogrel treatment in patients revascularized with coronary artery bypass grafting after myocardial infarction","volume":"57","author":"S\u00f8rensen","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B224","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.athoracsur.2013.08.058","article-title":"Effect of clopidogrel use post coronary artery bypass surgery on graft patency","volume":"97","author":"Ebrahimi","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"key\n\t\t\t\t20180531030839_suy019-B225","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1161\/CIRCULATIONAHA.110.978007","article-title":"Aspirin plus clopidogrel versus aspirin alone after coronary artery bypass grafting: the Clopidogrel After Surgery for Coronary Artery Disease (CASCADE) Trial","volume":"122","author":"Kulik","year":"2010","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180531030839_suy019-B226","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.athoracsur.2009.04.024","article-title":"Clopidogrel and aspirin versus clopidogrel alone on graft patency after coronary artery bypass grafting","volume":"88","author":"Gao","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"key\n\t\t\t\t20180531030839_suy019-B227","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.ahj.2010.07.035","article-title":"Randomized trial of aspirin and clopidogrel versus aspirin alone for the prevention of coronary artery bypass graft occlusion: the Preoperative Aspirin and Postoperative Antiplatelets in Coronary Artery Bypass Grafting study","volume":"160","author":"Sun","year":"2010","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t20180531030839_suy019-B228","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/j.jacc.2010.03.104","article-title":"Aspirin plus clopidogrel therapy increases early venous graft patency after coronary artery bypass surgery: a single-center, randomized, controlled trial","volume":"56","author":"Gao","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B229","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/jocs.12074","article-title":"Dual anti-platelet therapy after coronary artery bypass grafting: is there any benefit? A systematic review and meta-analysis","volume":"28","author":"Deo","year":"2013","journal-title":"J Card Surg"},{"key":"key\n\t\t\t\t20180531030839_suy019-B230","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.amjcard.2013.07.017","article-title":"Meta-analysis of effect of single versus dual antiplatelet therapy on early patency of bypass conduits after coronary artery bypass grafting","volume":"112","author":"Nocerino","year":"2013","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B231","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1345\/aph.1Q692","article-title":"Use of aspirin and clopidogrel after coronary artery bypass graft surgery","volume":"46","author":"de Leon","year":"2012","journal-title":"Ann Pharmacother"},{"key":"key\n\t\t\t\t20180531030839_suy019-B232","doi-asserted-by":"crossref","first-page":"E581","DOI":"10.1532\/HSF98.20061034","article-title":"Effect of clopidogrel on midterm graft patency following off-pump coronary revascularization surgery","volume":"9","author":"Ibrahim","year":"2006","journal-title":"Heart Surg Forum"},{"key":"key\n\t\t\t\t20180531030839_suy019-B233","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1136\/heartjnl-2012-302449","article-title":"Aspirin plus clopidogrel for optimal platelet inhibition following off-pump coronary artery bypass surgery: results from the CRYSSA (prevention of Coronary arteRY bypaSS occlusion After off-pump procedures) randomised study","volume":"98","author":"Mannacio","year":"2012","journal-title":"Heart"},{"key":"key\n\t\t\t\t20180531030839_suy019-B234","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ejcts.2005.11.033","article-title":"Postoperative clopidogrel improves mid-term outcome after off-pump coronary artery bypass graft surgery: a prospective study","volume":"29","author":"Gurbuz","year":"2006","journal-title":"Eur J Cardiothorac Surg"},{"key":"key\n\t\t\t\t20180531030839_suy019-B235","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.jacc.2010.10.029","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient Outcomes) trial","volume":"57","author":"Held","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B236","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1093\/ehjcvp\/pvv006","article-title":"Contemporary antithrombotic strategies in patients with acute coronary syndromes managed without revascularization: insights from the EYESHOT study","volume":"1","author":"De Luca","year":"2015","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"key\n\t\t\t\t20180531030839_suy019-B237","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.amjcard.2012.10.018","article-title":"Refining the role of antiplatelet therapy in medically managed patients with acute coronary syndrome","volume":"111","author":"Boden","year":"2013","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B238","doi-asserted-by":"crossref","first-page":"d3527","DOI":"10.1136\/bmj.d3527","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes intended for non-invasive management: substudy from prospective randomised PLATelet inhibition and patient Outcomes (PLATO) trial","volume":"342","author":"James","year":"2011","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20180531030839_suy019-B239","first-page":"816","article-title":"I pazienti con sindrome coronarica acuta senza sopraslivellamento persistente del tratto ST non sottoposti a rivascolarizzazione coronarica: una popolazione sottotrattata","volume":"17","author":"Menozzi","year":"2016","journal-title":"G Ital Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B240","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1056\/NEJMoa1406656","article-title":"Demographic and epidemiologic drivers of global cardiovascular mortality","volume":"372","author":"Roth","year":"2015","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180531030839_suy019-B241","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1177\/2048872612450520","article-title":"The management of acute myocardial infarction in the cardiological intensive care units in Italy: the \u2018BLITZ 4 Qualit\u00e0\u2019 campaign for performance measurement and quality improvement","volume":"1","author":"Olivari","year":"2012","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"key\n\t\t\t\t20180531030839_suy019-B242","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.jacc.2010.04.063","article-title":"Antithrombotic therapy in the elderly","volume":"56","author":"Capodanno","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B243","first-page":"3238","article-title":"Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis","volume":"36","author":"Andreotti","year":"2015","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180531030839_suy019-B244","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/j.jacc.2010.09.010","article-title":"ACCF\/ACG\/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF\/ACG\/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. A report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents","volume":"56","author":"Abraham","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B245","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/eurheartj\/ehr407","article-title":"High on-thienopyridine platelet reactivity in elderly coronary patients: the SENIOR-PLATELET study","volume":"33","author":"Silvain","year":"2012","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180531030839_suy019-B246","first-page":"64","article-title":"Documento di posizione della Societ\u00e0 Italiana di Cardiologia Interventistica (SICI-GISE): terapia antitrombotica nel paziente anziano con sindrome coronarica acuta","volume":"17","author":"Tarantini","year":"2016","journal-title":"G Ital Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B247","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/S0195-668X(03)00485-8","article-title":"Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE)","volume":"24","author":"Moscucci","year":"2003","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180531030839_suy019-B248","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1161\/CIRCULATIONAHA.107.694273","article-title":"Does comorbidity account for the excess mortality in patients with major bleeding in acute myocardial infarction?","volume":"116","author":"Spencer","year":"2007","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180531030839_suy019-B249","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1161\/CIRCULATIONAHA.108.828541","article-title":"Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress Adverse outcomes with Early implementation of the ACC\/AHA Guidelines) Bleeding Score","volume":"119","author":"Subherwal","year":"2009","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180531030839_suy019-B250","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1016\/j.jacc.2009.09.076","article-title":"A risk score to predict bleeding in patients with acute coronary syndromes","volume":"55","author":"Mehran","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B251","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1001\/jama.2012.17312","article-title":"Platelet function during extended prasugrel and clopidogrel therapy for patients with ACS treated without revascularization: the TRILOGY ACS platelet function substudy","volume":"308","author":"Gurbel","year":"2012","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20180531030839_suy019-B252","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jacc.2013.05.023","article-title":"Prasugrel 5 mg in the very elderly attenuates platelet inhibition but maintains noninferiority to prasugrel 10 mg in nonelderly patients: the GENERATIONS trial, a pharmacodynamic and pharmacokinetic study in stable coronary artery disease patients","volume":"62","author":"Erlinge","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B253","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1161\/CIRCOUTCOMES.111.964395","article-title":"Ticagrelor versus clopidogrel in elderly patients with acute coronary syndromes: a substudy from the Prospective Randomized PLATelet Inhibition and Patient Outcomes (PLATO) Trial","volume":"5","author":"Husted","year":"2012","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"key\n\t\t\t\t20180531030839_suy019-B254","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ijcard.2015.08.057","article-title":"Risk stratification for secondary prevention with ticagrelor and aspirin: a closer look to patient subsets from the PEGASUS-TIMI 54 trial","volume":"201","author":"Capodanno","year":"2015","journal-title":"Int J Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B255","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jacc.2013.09.070","article-title":"Frailty assessment in the cardiovascular care of older adults","volume":"63","author":"Afilalo","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B256","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.arr.2010.09.001","article-title":"Outcome instruments to measure frailty: a systematic review","volume":"10","author":"de Vries","year":"2011","journal-title":"Ageing Res Rev"},{"key":"key\n\t\t\t\t20180531030839_suy019-B257","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1503\/cmaj.050051","article-title":"A global clinical measure of fitness and frailty in elderly people","volume":"173","author":"Rockwood","year":"2005","journal-title":"CMAJ"},{"key":"key\n\t\t\t\t20180531030839_suy019-B258","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jamda.2009.09.015","article-title":"In search of an integral conceptual definition of frailty: opinions of experts","volume":"11","author":"Gobbens","year":"2010","journal-title":"J Am Med Dir Assoc"},{"key":"key\n\t\t\t\t20180531030839_suy019-B259","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/1477-7525-8-123","article-title":"A reliable measure of frailty for a community dwelling older population","volume":"8","author":"Kamaruzzaman","year":"2010","journal-title":"Health Qual Life Outcomes"},{"key":"key\n\t\t\t\t20180531030839_suy019-B260","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1177\/2048872615581502","article-title":"Frailty is associated with worse outcomes in non-ST-segment elevation acute coronary syndromes: Insights from the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial","volume":"5","author":"White","year":"2016","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"key\n\t\t\t\t20180531030839_suy019-B261","first-page":"839","article-title":"Documento ANMCO\/SICI-GISE sulla terapia antiaggregante nelle sindromi coronariche acute","volume":"14","author":"De Luca","year":"2013","journal-title":"G Ital Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B262","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1161\/CIRCULATIONAHA.109.853135","article-title":"Minimizing the risks of anticoagulants and platelet inhibitors","volume":"121","author":"Alexander","year":"2010","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180531030839_suy019-B263","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1093\/eurheartj\/ehr204","article-title":"Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology","volume":"32","author":"Steg","year":"2011","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180531030839_suy019-B264","first-page":"31S","article-title":"La terapia alla dimissione tra standardizzazione e personalizzazione","volume":"9(7 Suppl 1)","author":"Mureddu","year":"2008","journal-title":"G Ital Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B265","first-page":"378","article-title":"Gestione multidisciplinare del paziente con sindrome coronarica acuta e diabete mellito: dalla terapia antitrombotica al trattamento dell\u2019iperglicemia","volume":"15","author":"Rossini","year":"2014","journal-title":"G Ital Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B266","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1093\/eurheartj\/ehq325","article-title":"Ticagrelor vs clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial","volume":"31","author":"James","year":"2010","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180531030839_suy019-B267","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1093\/eurheartj\/eht108","article-title":"ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD)","volume":"34","author":"Ryd\u00e9n","year":"2013","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180531030839_suy019-B268","doi-asserted-by":"crossref","first-page":"134","DOI":"10.5527\/wjn.v1.i5.134","article-title":"Chronic kidney disease in acute coronary syndromes","volume":"1","author":"Marenzi","year":"2012","journal-title":"World J Nephrol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B269","doi-asserted-by":"crossref","first-page":"563","DOI":"10.7326\/0003-4819-137-7-200210010-00007","article-title":"Acute myocardial infarction and renal dysfunction: a high-risk combination","volume":"137","author":"Wright","year":"2002","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20180531030839_suy019-B270","doi-asserted-by":"crossref","first-page":"555","DOI":"10.7326\/0003-4819-137-7-200210010-00006","article-title":"Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients","volume":"137","author":"Shlipak","year":"2002","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20180531030839_suy019-B271","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1161\/CIRCULATIONAHA.109.865352","article-title":"Use of evidence-based therapies in short-term outcomes of ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction in patients with chronic kidney disease: a report from the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network registry","volume":"121","author":"Fox","year":"2010","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180531030839_suy019-B272","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1016\/j.ehj.2004.08.016","article-title":"Association of glomerular filtration rate on presentation with subsequent mortality in non-ST-segment elevation acute coronary syndrome; observations in 13,307 patients in five TIMI trials","volume":"25","author":"Gibson","year":"2004","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180531030839_suy019-B273","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1161\/CIRCULATIONAHA.108.838169","article-title":"Influence of renal function on the effects of early revascularization in non-ST-elevation myocardial infarction: data from the Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART)","volume":"120","author":"Szummer","year":"2009","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180531030839_suy019-B274","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1161\/CIRCULATIONAHA.109.933796","article-title":"Ticagrelor versus clopidogrel in acute coronary syndromes in relation to renal function: results from the Platelet Inhibition and Patient Outcomes (PLATO) trial","volume":"122","author":"James","year":"2010","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180531030839_suy019-B275","first-page":"400","article-title":"Efficacy and safety of ticagrelor for long-term secondary prevention of atherothrombotic events in relation to renal function: insights from the PEGASUS-TIMI 54 trial","volume":"37","author":"Magnani","year":"2016","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180531030839_suy019-B276","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1016\/j.jacc.2016.11.007","article-title":"2016 AHA\/ACC Guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"69","author":"Gerhard-Herman","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B277","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMcp1507631","article-title":"Peripheral artery disease","volume":"374","author":"Kullo","year":"2016","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180531030839_suy019-B278","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.atherosclerosis.2004.03.009","article-title":"Prevalence, risk factors and cardio-vascular comorbidity of symptomatic peripheral arterial disease in Italy","volume":"175","author":"Brevetti","year":"2004","journal-title":"Atherosclerosis"},{"key":"key\n\t\t\t\t20180531030839_suy019-B279","doi-asserted-by":"crossref","first-page":"e5208","DOI":"10.1136\/bmj.e5208","article-title":"Diagnosis and management of peripheral arterial disease","volume":"345","author":"Peach","year":"2012","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20180531030839_suy019-B280","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1161\/CIRCULATIONAHA.110.003954","article-title":"Secondary prevention and mortality in peripheral artery disease: National Health and Nutrition Examination Study, 1999 to 2004","volume":"124","author":"Pande","year":"2011","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180531030839_suy019-B281","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1093\/eurheartj\/eht288","article-title":"Recent trends in morbidity and in-hospital outcomes of in-patients with peripheral arterial disease: a nationwide population-based analysis","volume":"34","author":"Malyar","year":"2013","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180531030839_suy019-B282","first-page":"218","article-title":"prevalence of risk factors in patients with peripheral arterial disease: a clinical and epidemiological evaluation","volume":"11","author":"Novo","year":"1992","journal-title":"Int Angiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B283","first-page":"25","article-title":"Patologia ostruttiva cronica aorto-iliaca e delle arterie degli arti inferiori","volume":"22(3 Suppl 2)","author":"Peinetti","year":"2015","journal-title":"Ital J Vasc Endovasc Surg"},{"key":"key\n\t\t\t\t20180531030839_suy019-B284","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(13)61249-0","article-title":"Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis","volume":"382","author":"Fowkes","year":"2013","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180531030839_suy019-B285","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.2337\/diacare.26.12.3333","article-title":"Peripheral arterial disease in people with diabetes","volume":"26","author":"American Diabetes Association","year":"2003","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t20180531030839_suy019-B286","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1001\/jama.295.2.180","article-title":"International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis","volume":"295","author":"Bhatt","year":"2006","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20180531030839_suy019-B287","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1093\/eurheartj\/ehu071","article-title":"Non-coronary atherosclerosis","volume":"35","author":"Gallino","year":"2014","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180531030839_suy019-B288","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1001\/jama.297.11.1197","article-title":"One-year cardiovascular event rates in outpatients with atherothrombosis","volume":"297","author":"Steg","year":"2007","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20180531030839_suy019-B289","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1159\/000306640","article-title":"Peripheral arterial disease as an independent predictor for excess stroke morbidity and mortality in primary-care patients: 5-year results of the getABI study","volume":"29","author":"Meves","year":"2010","journal-title":"Cerebrovasc Dis"},{"key":"key\n\t\t\t\t20180531030839_suy019-B290","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1177\/1358863X16643603","article-title":"Mortality rates at 10 years are higher in diabetic than in non-diabetic patients with chronic lower extremity peripheral arterial disease","volume":"21","author":"Mueller","year":"2016","journal-title":"Vasc Med"},{"key":"key\n\t\t\t\t20180531030839_suy019-B291","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1093\/eurheartj\/ehv006","article-title":"Peripheral arterial disease and critical limb ischaemia: still poor outcomes and lack of guideline adherence","volume":"36","author":"Reinecke","year":"2015","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180531030839_suy019-B292","first-page":"e002938","article-title":"Critical limb ischemia: current trends and future directions","volume":"5","author":"Teraa","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B293","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0002-9149(03)00632-5","article-title":"Prevalence of left main coronary artery disease, of three- or four-vessel coronary artery disease, and of obstructive coronary artery disease in patients with and without peripheral arterial disease undergoing coronary angiography for suspected coronary artery disease","volume":"92","author":"Sukhija","year":"2003","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B294","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1161\/CIRCULATIONAHA.115.016424","article-title":"Population-based study of incidence, risk factors, outcome, and prognosis of ischemic peripheral arterial events. Implications for prevention","volume":"132","author":"Howard","year":"2015","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180531030839_suy019-B295","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ijcard.2013.12.004","article-title":"Lower extremities peripheral arterial disease among patients admitted to cardiac rehabilitation: the THINKPAD registry","volume":"171","author":"Ambrosetti","year":"2014","journal-title":"Int J Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B296","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.jacc.2010.10.034","article-title":"Peripheral arterial disease and progression of coronary atherosclerosis","volume":"57","author":"Hussein","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B297","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.ijcard.2012.11.033","article-title":"Peripheral artery disease and outcomes after myocardial infarction: an individual-patient meta-analysis of 28,771 patients in CAPRICORN, EPHESUS, OPTIMAAL and VALIANT","volume":"168","author":"Inglis","year":"2013","journal-title":"Int J Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B298","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.jacc.2007.11.077","article-title":"Long-term prognosis of patients with peripheral arterial disease: a comparison in patients with coronary artery disease","volume":"51","author":"Welten","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B299","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1177\/0003319712466730","article-title":"Peripheral arterial disease: implications beyond the peripheral circulation","volume":"64","author":"Paraskevas","year":"2013","journal-title":"Angiology"},{"key":"key\n\t\t\t\t20180531030839_suy019-B300","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.amjcard.2010.11.019","article-title":"Risk of death and myocardial infarction in patients with peripheral arterial disease undergoing percutaneous coronary intervention (from the National Heart, Lung and Blood Institute Dynamic Registry)","volume":"107","author":"Parikh","year":"2011","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B301","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1177\/2047487314533215","article-title":"Cardiovascular events in acute coronary syndrome patients with peripheral arterial disease treated with ticagrelor compared with clopidogrel: data from the PLATO Trial","volume":"22","author":"Patel","year":"2015","journal-title":"Eur J Prev Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B302","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1161\/CIRCRESAHA.114.303505","article-title":"Pharmacological treatment and current management of peripheral artery disease","volume":"116","author":"Bonaca","year":"2015","journal-title":"Circ Res"},{"key":"key\n\t\t\t\t20180531030839_suy019-B303","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1611688","article-title":"Ticagrelor versus clopidogrel in symptomatic peripheral artery disease","volume":"376","author":"Hiatt","year":"2017","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180531030839_suy019-B304","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1161\/CIRCULATIONAHA.112.108787","article-title":"Missed opportunities. Despite improvement in use of cardioprotective medications among patients with lower-extremity peripheral artery disease, underuse remains","volume":"126","author":"Subherwal","year":"2012","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180531030839_suy019-B305","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jvs.2015.01.051","article-title":"Association of dual-antiplatelet therapy with reduced major adverse cardiovascular events in patients with symptomatic peripheral arterial disease","volume":"62","author":"Armstrong","year":"2015","journal-title":"J Vasc Surg"},{"key":"key\n\t\t\t\t20180531030839_suy019-B306","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/eurheartj\/ehn534","article-title":"Patients with peripheral arterial disease in the CHARISMA trial","volume":"30","author":"Cacoub","year":"2009","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180531030839_suy019-B307","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1001\/jamacardio.2016.2811","article-title":"Prolonged vs short duration of dual antiplatelet therapy after percutaneous coronary intervention in patients with or without peripheral arterial disease: a subgroup analysis of the PRODIGY randomized clinical trial","volume":"1","author":"Franzone","year":"2016","journal-title":"JAMA Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B308","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1161\/CIRCULATIONAHA.113.001560","article-title":"Management of patients after endovascular interventions for peripheral artery disease","volume":"128","author":"Sobieszczyk","year":"2013","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180531030839_suy019-B309","doi-asserted-by":"crossref","first-page":"e0135692","DOI":"10.1371\/journal.pone.0135692","article-title":"Comparative efficacy and safety of different antiplatelet agents for prevention of major cardiovascular events and leg amputations in patients with peripheral arterial disease: a systematic review and network meta-Analysis","volume":"10","author":"Katsanos","year":"2015","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180531030839_suy019-B310","first-page":"679","article-title":"Dual antiplatelet therapy in peripheral arterial disease and after peripheral percutaneous revascularization","volume":"24","author":"Hanna","year":"2012","journal-title":"J Invasive Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B311","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1016\/j.jacc.2016.03.524","article-title":"Ticagrelor for prevention of ischemic events after myocardial infarction in patients with peripheral artery disease","volume":"67","author":"Bonaca","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B312","doi-asserted-by":"crossref","first-page":"S:S5","DOI":"10.1016\/j.jvs.2006.12.037","article-title":"Inter-Society Consensus for the management of peripheral arterial disease (TASC II)","volume":"45 Suppl","author":"Norgren","year":"2007","journal-title":"J Vasc Surg"},{"key":"key\n\t\t\t\t20180531030839_suy019-B313","doi-asserted-by":"crossref","first-page":"e669S","DOI":"10.1378\/chest.11-2307","article-title":"Antithrombotic therapy in peripheral artery disease. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141(Suppl)","author":"Alonso-Coello","year":"2012","journal-title":"Chest"},{"key":"key\n\t\t\t\t20180531030839_suy019-B314","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1161\/CIR.0b013e31828b82aa","article-title":"Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF\/AHA guideline recommendations): a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"127","author":"Anderson","year":"2013","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180531030839_suy019-B315","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","article-title":"2017 ESC Guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS): document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries. Endorsed by: the European Stroke Organization (ESO). The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS)","volume":"39","author":"Aboyans","year":"2018","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180531030839_suy019-B316","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.jcin.2013.06.015","article-title":"Risk of stent thrombosis among bare-metal stents, first-generation drug-eluting stents, and second-generation drug-eluting stents: results from a registry of 18 334 patients","volume":"6","author":"Tada","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"key":"key\n\t\t\t\t20180531030839_suy019-B317","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1161\/CIRCULATIONAHA.114.014796","article-title":"Impact of diabetes mellitus on hospitalization for heart failure, cardiovascular events, and death: outcomes at 4 years from the Reduction of Atherothrombosis for Continued Health (REACH) Registry","volume":"132","author":"Cavender","year":"2015","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180531030839_suy019-B318","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/eurheartj\/ehv769","article-title":"The search for optimal dual antiplatelet therapy after PCI: fine-tuning of initiation and duration","volume":"37","author":"Luscher","year":"2016","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180531030839_suy019-B319","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1161\/CIRCULATIONAHA.112.124248","article-title":"Reduction in first and recurrent cardiovascular events with ticagrelor compared with clopidogrel in the PLATO Study","volume":"127","author":"Kohli","year":"2013","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180531030839_suy019-B320","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1161\/CIRCULATIONAHA.113.002589","article-title":"Stent thrombosis with ticagrelor versus clopidogrel in patients with acute coronary syndromes: an analysis from the prospective randomized PLATO trial","volume":"128","author":"Steg","year":"2013","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180531030839_suy019-B321","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"Intensive versus moderate lipid lowering with statins after acute coronary syndromes","volume":"350","author":"Cannon","year":"2004","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180531030839_suy019-B322","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S0140-6736(08)60422-5","article-title":"Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial","volume":"371","author":"Wiviott","year":"2008","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180531030839_suy019-B323","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s11239-014-1159-1","article-title":"Residual platelet reactivity to predict long-term clinical outcomes after clopidogrel loading in patients with acute coronary syndromes: comparison of different cutoff values by light transmission aggregometry from the responsiveness to clopidogrel and stent thrombosis 2-acute coronary syndrome (RECLOSE 2-ACS) study","volume":"40","author":"Valenti","year":"2015","journal-title":"J Thromb Thrombolysis"},{"key":"key\n\t\t\t\t20180531030839_suy019-B324","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1016\/j.jacc.2016.03.529","article-title":"Reduction in ischemic events with ticagrelor in diabetic patients with prior myocardial infarction in PEGASUS-TIMI 54","volume":"67","author":"Bhatt","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B325","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1093\/eurheartj\/ehu298","article-title":"Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and\/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS)","volume":"35","author":"Lip","year":"2014","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180531030839_suy019-B326","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(06)68845-4","article-title":"Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial","volume":"367","author":"Connolly","year":"2006","journal-title":"Lancet."},{"key":"key\n\t\t\t\t20180531030839_suy019-B327","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0735-1097(96)00450-0","article-title":"Coronary stent placement in patients with acute myocardial infarction: comparison of clinical and angiographic outcome after randomization to antiplatelet or anticoagulant therapy","volume":"29","author":"Sch\u00f6mig","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B328","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/j.jacc.2013.02.036","article-title":"Triple therapy with aspirin, prasugrel, and vitamin K antagonists in patients with drug-eluting stent implantation and an indication for oral anticoagulation","volume":"61","author":"Sarafoff","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B329","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/clc.22486","article-title":"Ticagrelor in triple antithrombotic therapy: predictors of ischemic and bleeding complications","volume":"39","author":"Fu","year":"2016","journal-title":"Clin Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B330","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0140-6736(12)62177-1","article-title":"Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial","volume":"381","author":"Dewilde","year":"2013","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180531030839_suy019-B331","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1161\/CIRCULATIONAHA.112.115386","article-title":"Concomitant use of antiplatelet therapy with dabigatran or warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial","volume":"127","author":"Dans","year":"2013","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180531030839_suy019-B332","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1161\/CIRCULATIONAHA.111.090464","article-title":"Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trial","volume":"126","author":"Healey","year":"2012","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180531030839_suy019-B333","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1161\/CIRCULATIONAHA.111.055970","article-title":"Myocardial ischemic events in patients with atrial fibrillation treated with dabigatran or warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) trial","volume":"125","author":"Hohnloser","year":"2012","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180531030839_suy019-B334","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1056\/NEJMoa1611594","article-title":"Prevention of bleeding in patients with atrial fibrillation undergoing PCI","volume":"375","author":"Gibson","year":"2016","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180531030839_suy019-B335","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJMoa1708454","article-title":"Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation","volume":"377","author":"Cannon","year":"2017","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180531030839_suy019-B336"},{"key":"key\n\t\t\t\t20180531030839_suy019-B337"},{"key":"key\n\t\t\t\t20180531030839_suy019-B338","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1056\/NEJMoa1502000","article-title":"Idarucizumab for dabigatran reversal","volume":"373","author":"Pollack","year":"2015","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180531030839_suy019-B339","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1056\/NEJMoa1607887","article-title":"Andexanet alfa for acute major bleeding associated with factor Xa inhibitors","volume":"375","author":"Connolly","year":"2016","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180531030839_suy019-B340","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1016\/S0140-6736(15)60292-6","article-title":"Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial","volume":"385","author":"Valgimigli","year":"2015","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180531030839_suy019-B341","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.jcin.2016.04.014","article-title":"Radial versus femoral access for coronary interventions across the entire spectrum of patients with coronary artery disease: a meta-analysis of randomized trials","volume":"9","author":"Ferrante","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"key\n\t\t\t\t20180531030839_suy019-B342","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1093\/eurheartj\/eht042","article-title":"Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy","volume":"34","author":"Agewall","year":"2013","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180531030839_suy019-B343","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ahj.2016.01.015","article-title":"Impact of proton pump inhibitors on clinical outcomes in patients treated with a 6- or 24-month dual-antiplatelet therapy duration: Insights from the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY trial","volume":"174","author":"Gargiulo","year":"2016","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t20180531030839_suy019-B344","doi-asserted-by":"crossref","first-page":"379","DOI":"10.7326\/0003-4819-150-6-200903170-00006","article-title":"Aspirin to prevent cardiovascular disease: the association of aspirin dose and clopidogrel with thrombosis and bleeding","volume":"150","author":"Steinhubl","year":"2009","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20180531030839_suy019-B345","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S0140-6736(10)61088-4","article-title":"Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial","volume":"376","author":"Mehta","year":"2010","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180531030839_suy019-B346","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1111\/j.1538-7836.2011.04456.x","article-title":"Management of patients with recently implanted coronary stents on dual antiplatelet therapy who need to undergo major surgery","volume":"9","author":"Savonitto","year":"2011","journal-title":"J Thromb Haemost"},{"key":"key\n\t\t\t\t20180531030839_suy019-B347","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1136\/hrt.2011.224519","article-title":"Non-cardiac surgery in patients with coronary stents: the RECO study","volume":"97","author":"Albaladejo","year":"2011","journal-title":"Heart"},{"key":"key\n\t\t\t\t20180531030839_suy019-B348","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jacc.2006.10.004","article-title":"Noncardiac surgery after coronary stenting: early surgery and interruption of antiplatelet therapy are associated with an increase in major adverse cardiac events","volume":"49","author":"Schouten","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B349","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jcin.2009.03.014","article-title":"Characterization of post-operative risk associated with prior drug-eluting stent use","volume":"2","author":"Anwaruddin","year":"2009","journal-title":"JACC Cardiovasc Interv"},{"key":"key\n\t\t\t\t20180531030839_suy019-B350","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1001\/jama.2013.278787","article-title":"Risk of major adverse cardiac events following noncardiac surgery in patients with coronary stents","volume":"310","author":"Hawn","year":"2013","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20180531030839_suy019-B351","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1160\/TH14-05-0436","article-title":"Perioperative management of oral antiplatelet therapy and clinical outcomes in coronary stent patients undergoing surgery. Results of a multicentre registry","volume":"113","author":"Rossini","year":"2015","journal-title":"Thromb Haemost."},{"key":"key\n\t\t\t\t20180531030839_suy019-B352","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1056\/NEJMoa1401105","article-title":"Aspirin in patients undergoing noncardiac surgery","volume":"370","author":"Devereaux","year":"2014","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180531030839_suy019-B353","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1093\/eurheartj\/ehu282","article-title":"2014 ESC\/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA)","volume":"35","author":"Kristensen","year":"2014","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180531030839_suy019-B354","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1016\/j.jacc.2014.07.944","article-title":"2014 ACC\/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines","volume":"64","author":"Fleisher","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B355","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1001\/jama.293.17.2126","article-title":"Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents","volume":"293","author":"Iakovou","year":"2005","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20180531030839_suy019-B356","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.amjcard.2010.08.067","article-title":"Prevalence, predictors, and long-term prognosis of premature discontinuation of oral antiplatelet therapy after drug eluting stent implantation","volume":"107","author":"Rossini","year":"2011","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B357","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1016\/j.jacc.2014.09.072","article-title":"The incremental risk of noncardiac surgery on adverse cardiac events following coronary stenting","volume":"64","author":"Holcomb","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B358","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1046\/j.1525-1497.2001.016008507.x","article-title":"Adverse cardiac events after surgery: assessing risk in a veteran population","volume":"16","author":"Kumar","year":"2001","journal-title":"J Gen Intern Med"},{"key":"key\n\t\t\t\t20180531030839_suy019-B359","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1097\/00000542-199803000-00005","article-title":"Myocardial infarction after noncardiac surgery","volume":"88","author":"Badner","year":"1998","journal-title":"Anesthesiology"},{"key":"key\n\t\t\t\t20180531030839_suy019-B360","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/00001721-199601000-00010","article-title":"Abnormally high platelet activity after discontinuation of acetylsalicylic acid treatment","volume":"7","author":"Beving","year":"1996","journal-title":"Blood Coagul Fibrinolysis"},{"key":"key\n\t\t\t\t20180531030839_suy019-B361","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1093\/eurheartj\/ehl334","article-title":"A systematic review and metaanalysis on the hazards of discontinuing or not adhering to aspirin among 50 279 patients at risk for coronary artery disease","volume":"27","author":"Biondi-Zoccai","year":"2006","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180531030839_suy019-B362","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/bja\/aeh147","article-title":"Triggers of perioperative myocardial ischaemia and infarction","volume":"93","author":"Priebe","year":"2004","journal-title":"Br J Anaesth"},{"key":"key\n\t\t\t\t20180531030839_suy019-B363","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1055\/s-0037-1615930","article-title":"Mechanisms of hypercoagulability","volume":"82","author":"Dahl","year":"1999","journal-title":"Thromb Haemost"},{"key":"key\n\t\t\t\t20180531030839_suy019-B364","doi-asserted-by":"crossref","first-page":"S715","DOI":"10.1016\/S0003-4975(02)04701-X","article-title":"Inflammatory response to cardiopulmonary bypass","volume":"75","author":"Levy","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"key\n\t\t\t\t20180531030839_suy019-B365","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.ejcts.2009.05.032","article-title":"Postoperative blood loss in patients undergoing coronary artery bypass surgery after preoperative treatment with clopidogrel. A prospective randomised controlled study","volume":"36","author":"Firanescu","year":"2009","journal-title":"Eur J Cardiothorac Surg"},{"key":"key\n\t\t\t\t20180531030839_suy019-B366","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.jcin.2010.03.021","article-title":"Frequency of major noncardiac surgery and subsequent adverse events in the year after drug-eluting stent placement: results from the EVENT (Evaluation of Drug-Eluting Stents and Ischemic Events) Registry","volume":"3","author":"Berger","year":"2010","journal-title":"JACC Cardiovasc Interv"},{"key":"key\n\t\t\t\t20180531030839_suy019-B367","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1016\/j.jacc.2016.09.967","article-title":"Risk associated with surgery within 12 months after coronary drug-eluting stent implantation","volume":"68","author":"Egholm","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B368","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jacc.2015.11.063","article-title":"Perioperative cardiovascular risk of prior coronary stent implantation among patients undergoing noncardiac surgery","volume":"67","author":"Mahmoud","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B369","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.amjcard.2009.06.038","article-title":"Timing of noncardiac surgery after coronary artery stenting with bare metal or drug-eluting stents","volume":"104","author":"van Kuijk","year":"2009","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B370","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/ALN.0b013e318186de1c","article-title":"Cardiac risk of noncardiac surgery after percutaneous coronary intervention with drug-eluting stents","volume":"109","author":"Rabbitts","year":"2008","journal-title":"Anesthesiology"},{"key":"key\n\t\t\t\t20180531030839_suy019-B371","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1056\/NEJM200009283431303","article-title":"Multiple complex coronary plaques in patients with acute myocardial infarction","volume":"343","author":"Goldstein","year":"2000","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180531030839_suy019-B372","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1161\/CIRCULATIONAHA.112.102715","article-title":"Risk of elective major noncardiac surgery after coronary stent insertion: a population-based study","volume":"126","author":"Wijeysundera","year":"2012","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180531030839_suy019-B373","doi-asserted-by":"crossref","first-page":"E13","DOI":"10.1002\/ccd.26629","article-title":"Antiplatelet therapy and outcome in patients undergoing surgery following coronary stenting: results of the surgery after stenting registry","volume":"89","author":"Rossini","year":"2017","journal-title":"Catheter Cardiovasc Interv"},{"key":"key\n\t\t\t\t20180531030839_suy019-B374","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1001\/jama.2011.2002","article-title":"Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial","volume":"307","author":"Angiolillo","year":"2012","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20180531030839_suy019-B375","first-page":"1455","article-title":"Management of antithrombotic therapy after bleeding in patients with coronary artery disease and\/or atrial fibrillation: expert consensus paper of the European Society of Cardiology Working Group on Thrombosis","volume":"38","author":"Halvorsen","year":"2017","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180531030839_suy019-B376","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/eurheartj\/ehn358","article-title":"Improving clinical out-comes by reducing bleeding in patients with non-ST-elevation acute coronary syndromes","volume":"30","author":"Budaj","year":"2009","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180531030839_suy019-B377","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1056\/NEJMoa062437","article-title":"Bivalirudin for patients with acute coronary syndromes","volume":"355","author":"Stone","year":"2006","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180531030839_suy019-B378","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(14)60924-7","article-title":"Unfractionated heparin versus bivalirudin in primary percutaneous coronary intervention (HEAT-PPCI): an open-label, single centre, randomised controlled trial","volume":"384","author":"Shahzad","year":"2014","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180531030839_suy019-B379","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1093\/eurheartj\/ehs012","article-title":"The association of in-hospital major bleeding with short-, intermediate-, and long-term mortality among older patients with non-ST-segment elevation myocardial infarction","volume":"33","author":"Lopes","year":"2012","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180531030839_suy019-B380","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1161\/CIRCULATIONAHA.106.612812","article-title":"Adverse impact of bleeding on prognosis in patients with acute coronary syndromes","volume":"114","author":"Eikelboom","year":"2006","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180531030839_suy019-B381","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jcin.2011.02.011","article-title":"Impact of bleeding on mortality after percutaneous coronary intervention: results from a patient-level pooled analysis of the REPLACE-2, ACUITY, and HORIZONS-AMI trials","volume":"4","author":"Mehran","year":"2011","journal-title":"JACC Cardiovasc Interv"},{"key":"key\n\t\t\t\t20180531030839_suy019-B382","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/ccd.25189","article-title":"Incidence and prognostic value of bleeding after percutaneous coronary intervention in patients older than 75 years of age","volume":"83","author":"Ndrepepa","year":"2014","journal-title":"Catheter Cardiovasc Interv"},{"key":"key\n\t\t\t\t20180531030839_suy019-B383","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jcin.2014.01.162","article-title":"Prognostic value of access site and nonaccess site bleeding after percutaneous coronary intervention: a cohort study in ST-segment elevation myocardial infarction and comprehensive meta-analysis","volume":"7","author":"Kikkert","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"key":"key\n\t\t\t\t20180531030839_suy019-B384","doi-asserted-by":"crossref","first-page":"737","DOI":"10.4244\/EIJY14M09_11","article-title":"Association of spontaneous and procedure-related bleeds with short- and long- term mortality after acute coronary syndromes: an analysis from the PLATO trial","volume":"11","author":"Ducrocq","year":"2015","journal-title":"EuroIntervention"},{"key":"key\n\t\t\t\t20180531030839_suy019-B385","doi-asserted-by":"crossref","first-page":"400","DOI":"10.4244\/EIJV3I3A71","article-title":"Prognostic impact of major bleeding in patients with acute coronary syndromes. A systematic review and meta-analysis","volume":"3","author":"Hamon","year":"2007","journal-title":"EuroIntervention"},{"key":"key\n\t\t\t\t20180531030839_suy019-B386","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.jacc.2007.02.027","article-title":"Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial","volume":"49","author":"Manoukian","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180531030839_suy019-B387","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0140-6736(15)00979-4","article-title":"Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials","volume":"387","author":"Cassese","year":"2016","journal-title":"Lancet"}],"container-title":["European Heart Journal Supplements"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/eurheartjsupp\/article-pdf\/20\/suppl_F\/F1\/24873015\/suy019.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T21:55:45Z","timestamp":1571435745000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartjsupp\/article\/20\/suppl_F\/F1\/5005913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,1]]},"references-count":387,"journal-issue":{"issue":"suppl_F","published-online":{"date-parts":[[2018,5,31]]},"published-print":{"date-parts":[[2018,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/suy019","relation":{},"ISSN":["1520-765X","1554-2815"],"issn-type":[{"value":"1520-765X","type":"print"},{"value":"1554-2815","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,5]]},"published":{"date-parts":[[2018,5,1]]}}}